Reuters logo
BRIEF-Wuhan Thalys Medical Technology jointly plans pharma tech JV worth 20 mln yuan
September 28, 2017 / 3:46 AM / in 25 days

BRIEF-Wuhan Thalys Medical Technology jointly plans pharma tech JV worth 20 mln yuan

Sept 28 (Reuters) - Wuhan Thalys Medical Technology Inc :

* Says it jointly plans Chengdu-based pharma tech JV worth 20 million yuan with an individual

* Says it will hold 51 percent stake in the JV

Source text in Chinese: goo.gl/s8jxJw

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below